Balance Sheet for Menlo Therapeutics Inc. (MNLO)

$ 2.24   0.04 (+1.82%) Volume: 6.43m 4:00 PM EDT May 22, 2020
After Hours:  $ 2.30   0.06 (+2.68%) Volume: 99.66k 7:58 PM EDT May 22, 2020
Statement: View:
Assets [+] in Thousands of Dollars
12/2019 12/2018 12/2017 12/2016 12/2015
Cash and Equivalents 30,777 49,510 10,206 4,027 43,808
Restrictable Cash - - - - -
Marketable Securities 46,167 86,740 49,295 26,881 -
Accounts Receivable - - 786 - -
Loans Receivable - - - - -
Other Receivables - - - - -
Receivables - - 786 - -
Inventories, Raw Materials - - - - -
Inventories, Work in Progress - - - - -
Inventories, Purchased Components - - - - -
Inventories, Finished Goods - - - - -
Inventories, Other - - - - -
Inventories, Adjustments & Allowances - - - - -
Inventories - - - - -
Prepaid Expenses 1,383 3,250 3,574 632 77
Current Deferred Income Taxes - - - - -
Other Current Assets - - - - -
Total Current Assets 78,327 139,500 63,861 31,540 43,885
Land and Improvements - - - - -
Buildings and Improvement - - - - -
Machinery, Furniture and Equipment - - - - -
Construction in Progress - - - - -
Fixed Assets, Other 769 146 28 27 -
Fixed Assets, Total 769 146 28 27 -
Gross Fixed Assets 769 146 28 27 -
Accumulated Depreciation - - - - -
Net Fixed Assets 769 146 28 27 -
Intangibles - - - - -
Cost in Excess - - - - -
Non-Current Deferred Income Taxes - - - - -
Other Non-Current Assets - - - - -
Total Non-Current Assets 842 428 3,006 10,513 -
Total Assets 79,169 139,928 66,867 42,053 43,885
Liabilities [+] in Thousands of Dollars
12/2019 12/2018 12/2017 12/2016 12/2015
Accounts Payable 3,771 3,290 2,462 1,526 637
Short Term Debt 700 - - - -
Notes Payable - - - - -
Accrued Expenses 5,705 6,103 3,358 518 80
Accrued Liabilities 5,705 6,103 3,358 518 80
Deferred Revenues - - 1,796 1,796 -
Current Deferred Income Taxes - - - - -
Other Current Liabilities 485 151 201 63 53
Total Current Liabilities 10,661 9,544 7,817 3,903 770
Long Term Debt N/A N/A - - -
Deferred Income Tax - - 6,735 8,531 -
Other Non-Current Liabilities (423) 7 6,757 8,588 65
Minority Interest - - - - -
Capital Lease Obligations 423 - - - -
Preferred Securities of Subsidiary Trust - - - - -
Preferred Equity Outside Shareholders' Equity - - 109,327 59,003 59,003
Total Non-Current Liabilities - 7 116,084 67,591 59,068
Total Liabilities 10,661 9,551 123,901 71,494 59,838
Preferred Shareholder's Equity - - - - -
Common Shareholder's Equity 68,508 130,377 (57,034) (29,441) (15,953)
Common Par 3 3 1 1 1
Additional Paid in Capital 252,820 241,106 2,207 699 93
Cumulative Translation Adjustments - - - - -
Retained Earnings (184,339) (110,636) (59,191) (30,115) (16,047)
Treasury Stock - - - - -
Other Equity Adjustments 24 (96) (51) (26) -
Total Capitalization 68,508 130,377 (57,034) (29,441) (15,953)
Total Equity 68,508 130,377 (57,034) (29,441) (15,953)
Total Liabilities & Shareholder's Equity 79,169 139,928 66,867 42,053 43,885
Cash Flow (73,712) (50,692) (29,149) (14,230) (4,608)
Working Capital 67,666 129,956 56,044 27,637 43,115
Free Cash Flow (65,112) (52,873) (28,249) (2,322) (4,183)
Invested Capital 68,508 130,377 (57,034) (29,441) (15,953)
Shares Outstanding - Common Class Only 24,403 23,233 - - -
Preferred Shares Outstanding - - - - -
Total Ordinary Shares 24,403 23,233 20,595 20,595 20,595
Total Common Shares Outstanding 24,403 23,233 - - -
Treasury Shares - - - - -
Basic Weighted Shares Outstanding 23,819 21,669 20,595 10,222 11,539
Diluted Weighted Shares Outstanding 23,819 21,669 20,595 10,222 11,539